Group names | Vaccines received | ||
---|---|---|---|
Dose 1 (Day 0) | Dose 2 (Day 21) | Dose 3 (Day 42) | |
Group A | TIV+Placebo | 15 μg | 15 μg |
Group B | TIV+Placebo | 3.75 μg/AS03 | 3.75 μg/AS03 |
Group C | 15 μg+TIV | 15 μg | Placebo |
Group D | 3.75 μg/AS03+TIV | 3.75 μg/AS03 | Placebo |
Group E | 15 μg+Placebo | 15 μg | TIV |
Group F | 3.75 μg/AS03+Placebo | 3.75 μg/AS03 | TIV |